Profound Medical Corp.
PROF | NASDAQ
$6.12
+$0.02 (+0.33%)
Sep 22, 2026, 11:44 AM ET · Market open
Market Data
Market Cap $221.66M
Enterprise Value $188.01M
Beta 0.53
Average Volume 86.91K
Shares Outstanding (Diluted) 36.35M
Shares Change YoY 20.95%
Institutional Ownership 45.01%
Exchange NASDAQ
ISIN CA74319B5027
Price Performance
Price Change 1M -10.3%
Price Change 3M -6.4%
Price Change 6M 4.8%
Price Change YTD -20.4%
Price Change 1Y 41.9%
Price Change 3Y -39.1%
Price Change 5Y -59.3%
1M CAGR (ann.) -17.7%
1Y CAGR (ann.) 47.7%
5Y CAGR (ann.) -15.7%
All-Time CAGR -6.5%
Valuation
PE Ratio -12.98
Forward PE N/A
PEG Ratio -0.15
Forward PEG 0.22
PS Ratio 11.66
Forward PS 5.20
PB Ratio 4.45
P/FCF Ratio -6.09
P/Adj. FCF Ratio -5.36
P/OCF Ratio -6.22
EV/Sales 9.89
EV/EBIT -5.58
EV/EBITDA -5.68
EV/FCF -5.17
Earnings Yield -7.7%
FCF Yield -16.4%
Adj. FCF Yield -18.6%
Financial Health
Net Cash $33.65M
Total Debt $4.63M
Cash & Short-Term Investments $38.27M
Total Assets $62.39M
Current Ratio 6.46
Quick Ratio 5.31
Debt / Equity Ratio 0.15
Debt / EBITDA -0.14
Debt / FCF -0.13
OCF / Debt -7.82
Interest Coverage 0.00
Altman Z-Score 3.22
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 71.7%
Operating Profit Margin -185.4%
EBITDA Margin -176.3%
Net Profit Margin -170.9%
FCF Margin -191.3%
Adj. FCF Margin -217.5%
SBC / Revenue 21.6%
SBC Impact (per share) -13.7%
Returns
Return on Assets -52.0%
Return on Equity -62.5%
Return on Invested Capital -60.5%
Return on Capital Employed -65.7%
Return on Tangible Assets -52.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 33.6%
Revenue CAGR 5Y 15.1%
Revenue CAGR 10Y 19.1%
EPS CAGR 3Y 36.0%
EPS CAGR 5Y 15.8%
EPS CAGR 10Y 9.8%
FCF CAGR 3Y -23.0%
FCF CAGR 5Y -13.0%
FCF CAGR 10Y -12.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 83.7%
Revenue Growth Next 3Y 77.0%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.23
EPS Growth Est (next Q) -11.5%
Revenue Est (next Q) $6.78M
Revenue Growth Est (next Q) 29.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11
Price Target Upside 80.3%
Cash Flow
Operating Cash Flow $-36.19M
Free Cash Flow $-36.37M
Adj. Free Cash Flow $-41.34M
FCF Per Share -$0.98
OCF Per Share -$0.98
OCF/S Ratio -187.8%
Income Statement
Revenue $19.01M
Gross Profit $13.65M
Operating Income $-35.26M
EBITDA $-33.09M
Net Income $-32.65M
EPS (Diluted) -$0.47
Revenue / Employee $117.36K
Profit / Employee $-201.53K
Employees 162
Add to Watchlist
Select watchlists to add or remove PROF